| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 10/grams
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Luliconazole |
| MOQ | 1kg |
| CAS | 187164-19-8 |
| Appearance | White Powder |
| Molecular Formula | C14H9Cl2N3S2 |
| Molecular Weight | 354.27 |
| Assay | >99% |
| Packing | 25kg/drum |
| Storage | Store in a well-closed,light-resistant container |
Luliconazole is a new type of imidazole topical antifungal drug, which is an analog of lanoconazole. It interferes with fungal cell wall synthesis and fungal growth by inhibiting the activity of lanosterol demethylase and reducing the level of ergosterol. In addition to being used in the treatment of tinea pedis, jock itch and tinea corporis, it has also been developed for the treatment of onychomycosis (onychomycosis).
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan.
For the following fungal infections:
1. Tinea: athlete's foot, body tinea, tinea femoral;
2. Candida infection: interphalangeal erosion, rubbing; purplish or white patches on the skin.
){kind=link}